Clinical Trials on Superficial Partial Thickness Burn in Switzerland
Total 1 results
-
La Tour HospitalRive Droite SAUnknownPlatelet-rich Plasma (PRP) | Supraspinatis Interstitial Partial-thickness TearsSwitzerland
Sponsors and Collaborators
- Azienda Unità Sanitaria Locale Reggio Emilia
- Craving Change
- Holger Dressel
- First People's Hospital of Shenyang
- Innovative Therapies, Inc.
- Amira Hussin Hussin Mohammed
- Colorado Childrens Hospital
- Ringerike sykehus, Vestre Viken HF
- CellMaxLife
- Ozden Gokcek
- Institute of Cancer Research (ICR), United Kingdom
- Tarek Alsaied
- Giovanni Mirabella
- Healthy Life
- Clinical Oncology department. Elmansoura University.
- Facultad de Estudios Superiores Aragón UNAM
- Secretariat of Public Education (SEP)
- Monroe Carell Jr. Children's Hospital at Vanderbilt
- Jorge Orduña-Valls
- Camille Levy
- View Full List
Medical Conditions
- Ascorbic Acid
- Skin and Subcutaneous Tissue Infection
- Homologous Recombination Deficient Solid Tumors
- Asthma, Allergic
- Human Herpes Virus-6 Infection
- Postoperative Analgesic Demand
- Body Height
- Drainage Procedure
- Angiotensin-Converting Enzyme Inhibitors
- Triple Negative Breast Cancer, TNBC
- Acute Myelogenous Leukemia (AML or ANLL)
- Emergency Geriatric Care
- Post-operative Intercostal Neuralgia
- CYP2C19 Poor
- Ventilator Induced Diaphragm Dysfunction
- Peripheral Neuropathy Associated With Anti-myelin Associated Glycoprotein Antibodies (Anti-MAG Neuropathy)
- Established Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD Risk
- Impulse-Control Disorders
- MINI MENTAL STATE EXAMINATION TEST
- Rectal Adenocarcinoma
- View Full List
Drug Interventions
- Luliconazole Cream 1% - 2 wks
- Leucovorin
- Fluvastatin
- Xenon
- Background regimen (BR) for MDR-TB (multi-drug resistant tuberculosis)
- Tenecteplase
- Topical Solution
- Standard of care
- Prolonged release (PR) OROS methylphenidate 72 mg
- RBS2418
- Antithymocyte globulin (Rabbit)
- Trastuzumab
- Enfuvirtide-intensified HAART
- GW-1000-02
- Octreotide
- BMS-770767
- Ascorbic Acid
- AZD7325
- AMT-101 (oral)
- Bevacizumab standard of care
- View Full List
CROs by country
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Belarus
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Burundi
- Contract Research Organizations in Chile
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Poland
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Tanzania
- Contract Research Organizations in Uganda
- Contract Research Organizations in United States
- Contract Research Organizations in Uzbekistan
- CRO list by country